| human | Q5 |
| P10057 | IRIS UNIMI author ID | 05508 |
| P496 | ORCID iD | 0000-0003-0877-365X |
| P3829 | Publons author ID | 2380500 |
| P1053 | ResearcherID | J-1907-2015 |
| P1556 | zbMATH author ID | bucciarelli.paolo |
| P69 | educated at | University of Milan | Q46210 |
| P108 | employer | Milan Polyclinic | Q1413761 |
| P734 | family name | Bucciarelli | Q37055128 |
| Bucciarelli | Q37055128 | ||
| Bucciarelli | Q37055128 | ||
| P735 | given name | Paolo | Q15731774 |
| Paolo | Q15731774 | ||
| P6104 | maintained by WikiProject | WikiProject Mathematics | Q8487137 |
| P106 | occupation | researcher | Q1650915 |
| P21 | sex or gender | male | Q6581097 |
| Q45877099 | A shortened activated partial thromboplastin time is associated with the risk of venous thromboembolism |
| Q35658142 | Activation of Blood Coagulation in Two Prototypic Autoimmune Skin Diseases: A Possible Link with Thrombotic Risk |
| Q73201895 | Alterations of haemostatic and fibrinolytic markers in adult patients with growth hormone deficiency and with acromegaly |
| Q43569902 | Anticoagulant treatment with rivaroxaban in severe protein S deficiency. |
| Q40684733 | Association between red cell distribution width and risk of venous thromboembolism. |
| Q45882932 | Baseline factor VIII plasma levels and age at first bleeding in patients with severe forms of von Willebrand disease |
| Q44794623 | Blood levels of homocysteine, folate, vitamin B6 and B12 in women using oral contraceptives compared to non-users |
| Q38248785 | Cerebral thrombosis and myeloproliferative neoplasms. |
| Q46340148 | Circulating and progenitor endothelial cells are abnormal in patients with different types of von Willebrand disease and correlate with markers of angiogenesis. |
| Q45882242 | Circulating endothelial cells (CECs) and progenitors (CEPs) in severe haemophiliacs with different clinical phenotype |
| Q45343578 | Circulating microparticles and risk of venous thromboembolism. |
| Q33381231 | Clinical and molecular predictors of thrombocytopenia and risk of bleeding in patients with von Willebrand disease type 2B: a cohort study of 67 patients |
| Q45868724 | Coagulation testing before epidural analgesia at delivery: cost analysis |
| Q40819096 | Duration of oral contraceptive use and the risk of venous thromboembolism. A case-control study. |
| Q45859145 | Effect of prothrombin 19911 A>G polymorphism on the risk of cerebral sinus-venous thrombosis |
| Q61040494 | Elevated prepartum fibrinogen levels are not associated with a reduced risk of postpartum hemorrhage |
| Q45863215 | Endothelial protein C receptor plasma levels increase in chronic liver disease, while thrombomodulin plasma levels increase only in hepatocellular carcinoma |
| Q45877995 | Evaluation of an heterogeneous group of patients with von Willebrand disease using an assay alternative to ristocetin induced platelet agglutination |
| Q47917570 | Factor V Leiden and G20210A prothrombin mutation and the risk of subclavian vein thrombosis in patients with breast cancer and a central venous catheter |
| Q57194073 | Factor v leiden mutation in patients with breast cancer with a central venous catheter: risk of deep vein thrombosis |
| Q44933363 | Fibrinogen Milano XIII (Aalpha 19 Arg-->Gly): a dysfunctional variant with an amino acid substitution in the N-terminal polymerization site. |
| Q42143381 | Hematological evaluation of acquired von Willebrand syndrome before oral surgery: Management of an unusual case |
| Q45864401 | Hemostatic abnormalities in Noonan syndrome |
| Q45884033 | High levels of factor VIII and risk of extra-hepatic portal vein obstruction |
| Q80843602 | High-D-dimer plasma levels predict poor outcome in esophageal variceal bleeding |
| Q45879887 | Identification of four novel polymorphisms in the Aalpha and gamma fibrinogen genes and analysis of association with plasma levels of the protein |
| Q104468511 | IgG subclasses as biomarkers for persistence of factor VIII inhibitors in previously untreated patients with severe haemophilia A |
| Q43646517 | Increased glucose-dependent insulinotropic polypeptide (GIP) secretion in acromegaly. |
| Q50870994 | Increased risk of venous thromboembolism in patients with bullous pemphigoid. The INVENTEP (INcidence of VENous ThromboEmbolism in bullous Pemphigoid) study. |
| Q45856951 | Influence of anticoagulant therapy with vitamin K antagonists on plasma levels of coagulation factor VIII. |
| Q45855734 | Influence of proband's characteristics on the risk for venous thromboembolism in relatives with factor V Leiden or prothrombin G20210A polymorphisms. |
| Q47304435 | Interleukin-10 and interleukin-6 gene polymorphisms as risk factors for Alzheimer's disease |
| Q45861333 | Long-term evaluation of the risk of recurrence after cerebral sinus-venous thrombosis |
| Q45880590 | Low borderline plasma levels of antithrombin, protein C and protein S are risk factors for venous thromboembolism |
| Q63247697 | Low levels of protein Z and the risk of venous thromboembolism |
| Q82603564 | Management of inherited von Willebrand disease in Italy: results from the retrospective study on 1234 patients |
| Q44563073 | Molecular diversity and thrombotic risk in protein S deficiency: the PROSIT study. |
| Q36473061 | New approaches for measuring coagulation. |
| Q45713731 | Normal reference ranges of antithrombin, protein C and protein S: effect of sex, age and hormonal status |
| Q76354490 | Patients with type 3 severe von Willebrand disease are not protected against atherosclerosis: results from a multicenter study in 47 patients |
| Q63247691 | Polymorphisms of the protein Z-dependent protease inhibitor (ZPI) gene and the risk of venous thromboembolism |
| Q45870427 | Predictors of von Willebrand disease diagnosis in individuals with borderline von Willebrand factor plasma levels |
| Q45858020 | Pregnancy outcome after a first episode of cerebral vein thrombosis |
| Q45863890 | Psychological impact of thrombosis in the young |
| Q45866195 | Pulmonary embolism in elderly patients: prognostic impact of the Cumulative Illness Rating Scale (CIRS) on short-term mortality |
| Q45861683 | Red cell distribution width and the risk of cerebral vein thrombosis: A case-control study |
| Q45876700 | Risk factors and recurrence rate of primary deep vein thrombosis of the upper extremities |
| Q45872338 | Risk factors for idiopathic sudden sensorineural hearing loss and their association with clinical outcome. |
| Q45874287 | Risk factors for postpartum hemorrhage in a cohort of 6011 Italian women |
| Q63247698 | Risk factors for thrombophilia in extrahepatic portal vein obstruction |
| Q34988616 | Risk factors for venous and arterial thrombosis |
| Q45864132 | Role of the JAK2 mutation in the diagnosis of chronic myeloproliferative disorders in splanchnic vein thrombosis |
| Q60683918 | Seasonal variation of venous thrombosis: a consecutive case series within studies from Leiden, Milan and Tromsø |
| Q45878282 | The JAK2 V617F mutation in patients with cerebral venous thrombosis |
| Q45864717 | The bleeding score predicts clinical outcomes and replacement therapy in adults with von Willebrand disease |
| Q37610388 | The hemostatic system through aging and menopause. |
| Q45874156 | The risk of venous thromboembolism in family members with mutations in the genes of factor V or prothrombin or both |
| Q60683906 | The “Pregnancy Health-care Program” for the prevention of venous thromboembolism in pregnancy |
| Q38173538 | Thrombophilic states. |
| Q30490386 | Towards the genetic basis of cerebral venous thrombosis-the BEAST Consortium: a study protocol. |
| Q46885242 | Usefulness of PFA-100 testing in the diagnostic screening of patients with suspected abnormalities of hemostasis: comparison with the bleeding time |
| Q28607612 | Venous Thrombosis Risk after Cast Immobilization of the Lower Extremity: Derivation and Validation of a Clinical Prediction Score, L-TRiP(cast), in Three Population-Based Case-Control Studies |
Search more.